We have obtained transgenic mice in which an erythropoietin-SVQO virus T antigen fusion gene is homologously recombined into the native Epo locus. This gene is expressed in a tissue-specific manner closely resembling that of the native Epo gene. Immunohistochemical detection of SVQO T antigen has been used to characterize the hepatic cell populations expressing the transgene. In mice stimulated by anaemia or hypobaric hypoxia, SV40 T antigen was demonstrated in two liver cell populations: a subset of hepa-RYTHROPOIETIN (Epo) is the principal regulator of red blood cell production. In adults, the major site of production is the kidney, with a lesser contribution from the liver.'.' In kidney disease, relative deficiency of Epo is an important component of the accompanying anaemia.3 The mechanism of this deficiency is not understood, nor is it known why hepatic production of the hormone is insufficient to compensate. To understand the regulation of erythropoiesis in health and disease, it has been an important goal to identify and characterize the cells responsible for Epo production.
RYTHROPOIETIN (Epo) is the principal regulator of red blood cell production. In adults, the major site of production is the kidney, with a lesser contribution from the liver.'.' In kidney disease, relative deficiency of Epo is an important component of the accompanying anaemia.3 The mechanism of this deficiency is not understood, nor is it known why hepatic production of the hormone is insufficient to compensate. To understand the regulation of erythropoiesis in health and disease, it has been an important goal to identify and characterize the cells responsible for Epo production.
In situ hybridization studies of kidney identified Epo mRNA in a population of peritubular interstitial cells in the renal cortex and outer med~lla.".~ Recent studies have identified these cells as the fibroblast-like type I interstitial ~ells.6.~ In the liver, in situ hybridization and cell separation studies in rodents indicate that a subpopulation of hepatocytes and a nonparenchymal cell type both express Epo.'.' These studies were not able to identify which of the nonparenchymal cells produce the hormone.
We have used marker gene expression in transgenic mice to characterize this cell population. During the production of mice bearing an Epo-SV40 T antigen (Epo-TAg) transgene, we fortuitously obtained one line (Epo-TAgH) in which homologous recombination integrated the transgene into the native Epo locus with complete conservation of the surrounding DNA (Fig 1) . We have reported that in the kidney of these animals expression of SV40 T antigen was confined to the fibroblastoid interstitial cells7
We report here the localization of expression of the homologously inserted Epo-TAg gene in liver. Two classes of cells expressed SV40 T antigen in the livers of hypoxic or anaemic mice: It0 cells (also known as fat-storing or perisinusoidal cells) and hepatocytes. The cells expressing the recombinant transgene were located near the central vein in each lobule; with more severe stimulation, cells were observed at increasing distance from this structure.
E MATERIALS AND METHODS
The Epo-TAgH mice used in this study contained a homologously inserted Epo-TAg fusion gene, in which SV40 T-antigen coding sequence was inserted into the 5' untranslated region of the Epo gene, 65 bp from the cap site (Fig 1) . Details of the production of these animals by direct zygote injection and the diagnosis of the homologous recombination have been reported elsewhere (line 134.3 LC7). Olac, Bicester, UK) or littermates; genotype was determined by analysis of DNA obtained from tail biopsies, using Southern transfer or the polymerase chain reaction. Acute anemia was induced by the intraperitoneal injection of phenylhydrazine (freshly prepared in aqueous solution and adjusted to pH 7.0 with NaOH). To produce an acute exacerbation of chronic anaemia in homozygous animals, a single injection of 60 mgkg was administered 24 hours before killing; otherwise, three injections of 60 m a g were administered 36, 24, and 12 hours before killing. For exposure to a hypoxic atmosphere, a hypobaric chamber was used to create an apparent altitude of 6,000 to 8,000 meters, monitored with a barometric altimeter (Thommen, Waldenburg, Switzerland). Hypobaric hypoxia was maintained for 72 hours before killing. Animals were killed by cervical dislocation and portions of the liver were prepared for RNA analysis and morphological studies.
RNA analysis. Liver was homogenized in 4 m o m guanidium thiocyanate; RNA was purified on a cesium chloride gradient and assayed by RNAse protection as previously described." In most assays, 400 pg of total RNA was hybridized to a riboprobe that crosses the cap site and protects a 120-bp fragment incorporating both Epo 5' untranslated region and W 4 0 T antigen sequence.
Immunohistochemistry.
A variety of methods of tissue preparation were used to obtain the most suitable compromise between preserved antigenicity and structural integrity during fixation. Tissue for cryosections was frozen in liquid nitrogen; sections (thickness, 5 pm) were cut onto glass slides, air-dried overnight, fixed in acetone at room temperature for 10 minutes, and stored at -20°C before use.
In other animals, the liver was perfused for 15 minutes with fixative (2% paraformaldehyde-0.075 m o m L-lysine monohydrochloride-0.01 m o m sodium periodate in 0.1 m o m phosphate buffer). The fixed liver was then embedded in paraffin and sections were cut at 3 pm. These sections were dewaxed in xylene and subjected to microwave restoration (in 0.01 mom sodium citrate at 750 W for 10 minutes) before immunostaining for SV40 T antigen. Before labeling for 5'NT, the dewaxed sections were digested with subtilisin 125 ,ug/mL (Type XXIV protease; Sigma, Poole, UK) dissolved in phosphate-buffered saline (PBS) at 37°C for 20 minutes.
For immunohistochemical detection of SV40 T antigen, sections were first treated for 10 minutes with 0.3% hydrogen peroxide/ 0.01 m o m sodium azide in Tris-buffered saline (TBS) to block endogenous peroxidase activity. They were then incubated with polyclonal rabbit antiserum to SV40 T antigen or normal rabbit serum (1:1,000 in TBS) for 30 minutes, followed by horseradish peroxidase (HRP)-conjugated swine antirabbit Igs (DAKO M S , Glostrup, Denmark) for 30 minutes. Nickel-enhanced 3',3'diaminobenzidine (DAB) was used to detect peroxidase. In single-labeling experiments, the sections were then counter-stained lightly with haematoxylin. In double-labeling studies (which were performed on frozen sections), SV40 T antigen was stained first, and the second procedure was performed immediately thereafter. The antibodies used are shown in Table  Three techniques were used. (1) For double-labeling studies with rat monoclonal antibodies (MoAbs), the sections were incubated with MoAbs for 30 minutes followed by alkaline phosphatase-conjugated swine antirat Fab fragments (Boehringer Mannheim, Mannheim, Germany) for 30 minutes. Fast Red was used to detect alkaline phosphatase.
(2) For ecto-5'-nucleotidase (5'NT) the sections were incubated with normal rabbit serum (1: 1,000 in TBS) for 10 minutes to saturate the HRP-conjugated secondary antibody used to label SV40 T antigen. This was followed by incubation with polyclonal rabbit antiserum to 5'NT (1 : 1,000 in TBS) for 30 minutes, and alkaline phosphatase-conjugated swine antirabbit Igs (DAKO MS). Fast Red was used to detect alkaline phosphatase.
(3) For desmin, a mouse MoAb directly coupled to HRP via an inert polymer backbone was used (EPOS antidesmin; DAKO AIS). After labeling for SV40 T antigen, the sections were incubated with the EPOS-conjugated MoAb and then with DAB as peroxidase substrate.
Single-labeling for 5'NT was performed with peroxidase detection by the same method as peroxidase-labeling for SV40 T antigen. Appropriate controls (normal rabbit serum for polyclonal antibodies, diluent for rat MoAbs, and EPOS control reagent [DAKO M S ] for EPOS-MoAb) were performed on adjacent sections on the same slide in all experiments.
Immunoelectronmicroscopy. Liver was either perfusion-fixed (see above) or small pieces of tissue were fixed by immersion in 2% paraformaldehyde in 0.1 m o m phosphate buffer for 2 hours. Samples were then rapidly dehydrated through cold ethanol, which was then replaced by a 1 : 1 mixture of ethano1:LR White resin (London Resin CO, Basingstoke, UK) for 1 hour before overnight impregnation in pure LR White resin at -20°C. The tissue was then embedded in LR White resin and the blocks were polymerised for 20 hours at 70°C. One-micron sections were cut and stained with Azure A for light microscopy. Selected areas were then sectioned with a diamond knife and placed on nickel grids for immunostaining. A three-stage staining protocol was used, with 1% bovine serum albumin (BSA) and 1% Tween included in the staining solutions to reduce nonspecific background. Grids were first floated on 25-pL drops of rabbit polyclonal antisera (diluted 1:1,000) to SV40 T antigen, 5'NT, or Toxoplasma gondii (negative control) for 2 hours. This was followed by goat antirabbit Igs (Sigma) diluted 150 for 1 hour and finally rabbit antigoat Igs conjugated to 10 nm colloidal gold (BioCell Ltd, Cardiff, UK) diluted 1:25 for 30 minutes. The grids were then stained with 2% uranyl acetate for 6 minutes before examination with a Jeol lOOCX electron microscope (Jeol, Tokyo, Japan).
RESULTS
Phenotype of Epo-TAgH mice and mRNA expression. In heterozygous Epo-TAgH mice bearing one native Epo-gene and one Epo-TAg gene, the organ distribution of Epo-TAg mRNA paralleled that of the native Epo mRNA. The highest level of expression was observed in kidney, with a lower level in liver and low levels in brain, testis, and preputial gland.' Heterozygous Epo-TAgH mice were mildly anaemic compared with nontransgenic controls (hematocrit 0.34 L 0.04 v 0.43 2 0.05). Homozygous Epo-TAg" mice have a more severe anemia (hematocrit, 0.13 5 0.03). Although both copies of the native Epo gene have been replaced, these mice have detectable levels of immunoreactive Epo by radioimmunoassay. RNase protection demonstrates the transcription of Epo sequence 3' to the SV40 polyadenylation site (data not shown). A low level of Epo production is therefore maintained from transcripts running through the viral polyA signal into Epo coding sequence.
In unstimulated heterozygous mice, Epo-TAg mRNA was not detected in the liver. As expected, in the homozygous Epo-TAgH mice, chronic anemia results in a high level of expression of the Epo-TAg gene in the kidney and a low, but detectable level in the liver. Mice were rendered more anemic using phenylhydrazine; this resulted in increased levels of Epo-TAg mRNA in the liver of both heterozygous and homozygous Epo-TAgH mice (Fig 2) .
Localization of W 4 0 Tantigen in the liver. Immunohistochemical studies of SV40 T antigen expression were performed on both heterozygous and homozygous Epo-TAgH mice; adult animals, aged 1 to 6 months, were used. When compared with nontransgenic controls, no abnormality of hepatic morphology was discerned, either in heterozygotes or homozygotes. However, after treatment with phenylhydrazine, occasional centrilobular cell damage was sometimes observed both in transgenic and nontransgenic mice. Initial studies of the cellular localization and distribution of hepatic SV40 T antigen expression were performed on cryostat sections using a polyclonal rabbit antiserum. In unstimulated heterozygote Epo-TAgH mice, no staining for SV40 T antigen was detected, consistent with the lack of detectable Epo-TAg mRNA in the liver. In the chronically anemic homozygous Epo-TAgH mice, very few cells were positive for SV40 T antigen. These were located away from identifiable portal triads, near the center of the lobule. A similar number and distribution of positive cells was observed in heterozygous Epo-TAgH mice subjected to acute anemic stimulation with phenylhydrazine. In contrast, severe stimulation, achieved by exposing homozygous Epo-TAg" mice to hypobaric hypoxia or phenylhydrazine-induced hemolysis, resulted in a substantially increased (approximately 20-fold) number of SV40 T-antigen-positive cells, which were located at increased distances from the central vein, but a clear pericentral distribution was still observed. The pattern of induced expression of SV40 T antigen was pericentral irrespective of whether the hypoxic stimulus was acute anemia, chronic anemia, or hypobaric hypoxia. No staining was ever observed in sections from nontransgenic control mice (with or without phenylhydrazine treatment), or when normal rabbit serum was substituted for the polyclonal antiserum on sections from the transgenic mice.
Perfusion-fixed, paraffin-embedded sections permitted the combination of localising SV40 T antigen with improved morphologic preservation. Two different populations of cells were found to contain SV40 T antigen. One was characterized by relatively irregular-shaped nuclei with little identifiable cytoplasm (Fig 3A) . The other, which was less frequent, consisted of hepatocytes, with large rounded nuclei and plentiful cytoplasm (Fig 3B) .
Double immunohistochemical labeling studies.
In addition to hepatocytes, the liver contains several nonparenchymal cell types. These include the macrophagelmonocyterelated Kupffer cells, the lymphocyte-related pit cells, the sinusoidal endothelial cells, and the perisinusoidal Ito cells.'9 Because SV40 T antigen is almost exclusively localized in the nucleus, immunohistochemical detection was readily combined with detection of cytoplasmic and cell surface markers in double-labeling studies ( Table 1) . Antibodies to three such markers were used to label Kupffer cells: rat MoAb F4180 to a surface antigen of mouse macrophages," rat MoAb M1/9.3.4.HL2 against leukocyte common antigen (CD45)," and the rat MoAb 2.462 that binds to low-affinity Fc receptors expressed on Kupffer cells and endothelial cells."," These antibodies all labeled nonhepatocyte populations clearly when applied in isolation, or in combination with SV40 T antigen staining. However, there was no overlap with the population of cells expressing SV40 T antigen. Leukocyte common antigen (CD45) is expressed not only by Kupffer cells but also by the lymphocyte-related pit cells, indicating that both these cell populations are distinct from the cells expressing SV40 T antigen (Fig 3C) . Endothelial cells in the liver express platelet endothelial cell adhesion molecule (PECAM, CD31), which was labeled using rat MoAb MEC13.3." Figure 3D shows a nucleus containing SV40 T antigen closely apposed to the nucleus and cell surface of an endothelial cell. In no instance was doublelabeling for SV40 T antigen and CD3 1 observed. This result is in keeping with the studies using 2.4G2, indicating that the cells expressing SV40 T antigen are not endothelial.
Ito cells possess long processes extending between the hepatocytes and express the intermediate filament protein, desmin, which provides a specific marker for these cells in rodent liver." Storage of vitamin A in lipid droplets is observed in most Ito cells but is most marked in the periportal regions." Using a directly conjugated mouse MoAb to desmin, characteristic staining of fine processes extending throughout the hepatic lobule was observed. When the antidesmin MoAb and antiserum to SV40 T antigen were combined, double staining was observed in individual cells (Fig  3E and F) . The majority, possibly all, of the nonparenchymal pericentral cell population expressing SV40 T antigen also stained for desmin. However, desmin-positive cells lying in the periportal region did not express SV40 T antigen even in the most stimulated animals.
5'NT is located on the biliary canaliculi of hepatocytes and on Ito cells in rodent liver." Using the same polyclonal rabbit antiserum to localize 5'NT in our anemic mice, labeling was seen in a pericentral distribution in the liver. In both perfusion-fixed material and frozen sections it was possible to identify staining of both biliary canaliculi and of nonparenchymal cells (Fig 3G) . When visualization of 5'NT was combined with labeling of SV40 T antigen, SV40 T antigen was observed in the nuclei of cells expressing a high level of 5'NT (Fig 3H) . Although a high proportion (possibly all) of the nonparenchymal SV40 T antigen-positive cells were positive for 5'NT, many 5'NT-positive cells did not contain SV40 T antigen.
Immunoelecrronmicro.~copv. Initially the ultrastructural features of the various cell types within the liver were examined in optimally fixed tissue. The appearance was similar to that previously described for rodent liver. The endothelial cells formed the sinusoids, with thin cytoplasmic processes interrupted by gaps and fenestrations. The Kupffer cells were normally located within the sinusoids and characterized by a variable number of large heterophagosomes containing debris. Rare lymphocyte-like cells were seen within the sinusoids that probably represented the pit cells.
The space of Disse, between the sinusoidal endothelium and the hepatocytes, contained numerous small cytoplasmic processes from the hepatocytes and a number of Ito cells. These cells were normally in close apposition to the hepato- cytes and were characterized by a variable number of large lipid droplets, which in many cases caused displacement or indentation of the nucleus. In the osmium-fixed material the lipid droplets were of a homogenous, slightly electron-dense appearance (Fig 4A) . The only other cells with lipid droplets were a small number of hepatocytes, which were identifiable by their other organelles. For immunoelectronmicroscopy, material was not fixed with osmium tetroxide and consequently was less well preserved ultrastructurally. However, it was possible to distinguish the cell types as described above. The It0 cells were identified within the space of Disse on the basis of the large cytoplasmic fat droplets that appeared as empty vacuoles, due to lipid extraction in the absence of osmium tetroxide (Fig 4B) . In sections stained for SV40 T antigen, staining was observed in the nuclei of It0 cells (Fig 4C) . However, not all It0 cells were labeled with gold particles. In positively stained cells, more gold particles were located over the electron-lucent euchromatin than over the electron-dense hetemchromatin. Although the number of gold particles was relatively low, it was markedly greater than that seen over the nuclei of other cell types and in negative controls, thus confirming the specificity of the staining. In sections stained for 5'NT, staining was observed on the cell membrane of It0 cells, and on their fine processes in the space of Disse (Fig 4D) .
DISCUSSION
In these experiments, expression of an Epo-SV40 T antigen transgene has been used to identify liver cells with the potential for Epo gene expression. The use of marker genes in transgenic animals for identification of specific cell populations requires that the expression of the transgene is, itself, tissue specific. The transgene used to create these animals contained the SV40 T antigen coding sequence inserted into the 5' untranslated region of the Epo gene. Epo sequence, including flanking sequences and the gene itself, was otherwise unchanged. Fortuitous integration of this construct into the native Epo locus therefore placed the marker gene under control of all potential cis-acting sequences with the least possible disturbance of their relative positions. As would be anticipated from this, RNase protection studies of the organ distribution of Epo-TAg mRNA in heterozygous animals showed an expression pattern that was closely similar to that of the unmodified Epo mRNA. This provides very strong support for the use of SV40 T antigen as a valid marker of cells with the potential for Epo expression, but clearly precludes direct demonstration of native Epo gene expression in homozygous mice, because both copies of the gene have been replaced. In heterozygous animals, direct demonstration of native Epo mRNA by in situ hybridization would also be confounded by transcripts running through the SV40 T-antigen poly A addition signals into Epo sequence. Consequently, we have not performed in situ hybridization studies on these mice; the appearance of our nonhepatocytic liver cell population is in keeping with the in situ hybridization studies reported by Koury et a18 and Schuster et al? Immune detection of SV40 T antigen provided the potential for further characterization of these cells.
Previous attempts to define this cell population have not been successful, although it has been suggested that the Kupffer cells can produce Epo?' The cell population defined in our studies as expressing SV40 T antigen did not express leukocyte, macrophage, or endothelial markers and therefore contains neither Kupffer nor endothelial cells. Immunohisto- SV40 T antigen expression in Ito cells was undetectable in unstimulated heterozygous animals, at the limit of detection in the chronic anaemic homozygous animals, but could be readily detected after further stimulation with hypobaric hypoxia or phenylhydrazine-induced hemolysis. In these severely stimulated animals, a clear lobular distribution of positive cells was observed in the pericentral regions. Such a distribution is in keeping with known oxygen gradients within the live?' and indicates that the cells are most probably responding directly to a low partial pressure of oxygen. Interestingly, a similar distribution of Epo mRNA was observed by Koury et a1' among hepatocytes of transgenic animals that overexpressed a human Epo transgene in liver.
The intensity of staining for SV40 T antigen that we observed in individual nuclei in the liver, both in hepatocytes and nonparenchymal cells, was lower than that seen in kidney from the same animal. Within the limits of such a comparison, this is consistent with in situ hybridization studies of Epo mRNA in which slides of liver required longer exposure times than those of kidney,'.' and suggests that the expression of Epo per cell in the liver is lower than in the kidney.
Although we also observed Epo-TAg expression in hepatocytes, this accounted for a relatively low proportion of the cells positive for SV40 T antigen (less than 10%). Lacombe et a l Z 2 have reported greater Epo mRNA content in nonparenchymal liver cells than in hepatocytes prepared from anaemic mice. However, Koury et al,' using in situ hybridization on anemic mouse liver, found that more hepatocytes expressed Epo mRNA than nonparenchymal cells. A similar result was obtained by Schuster et a19 in anemic, hypoxic rat liver. One possible explanation for this difference is that we have studied the effect of hypoxia or hemolysis on the background of a chronic anemia, and this may have resulted in differential adaptive changes in Epo expression in hepatocytes and Ito cells. Alternatively, it is possible that the presence of the SV40 T-antigen coding sequence in Epo-TAg influenced the relative level of expression of the gene in these cells, despite the preservation of all Epo sequence. This could, for instance, be caused by the distancing of the 3' enhancer region from the Epo promoter. Some support for this possibility was provided by RNAse protection studies of Epo TAg mRNA and native Epo mRNA in heterozygous animals. The level of Epo-TAg mRNA in the liver was in the region of fourfold lower than that of native Epo mRNA. In contrast, in the kidney, the levels of Epo-TAg and native Epo mRNA were very similar (mean ratio, 1.0; range, 0.7 to 1.5). It is therefore possible that in the kidney and Ito cells the EpoTAg gene is expressed at a quantitatively similar level to the native gene, but that in hepatocytes the insertion of SV40 sequence has led to reduced expression. Finally, the expression of SV40 T antigen, a viral oncogene, in Ito cells may have led to expansion of this population, although this was not evident when liver histology was compared with that of nontransgenic mice.
Epo mRNA has been identified in a nonhepatocyte population separated by metrizamide gradient centrifugation.' The investigators did not comment on whether their use of this technique would enable purification of Ito cells, but similar methods have been applied to separate Ito cells on the basis of the altered buoyant density arising from fat storage." Such methodology might represent a way of obtaining Epoproducing Ito cells in tissue culture, but there are two potential problems. Firstly, although some fat-storing cells did express SV40 T antigen, fat storage is not universal in the Ito cell population, and the most heavily fat-laden cells are in the periportal zones where SV40 T-antigen and presumably Epo gene expression is not observed in vivo." Equally, it may be that when exposed to hypoxia in tissue culture these periportal cells would express Epo. The second potential problem is that our attempts to explant the similar fibroblastoid cell population from the kidneys of these mice have so far not met with success, raising the possibility that EpoTAg and Epo expression in this cell type is rapidly suppressed when cells are grown in tissue culture.
At the current time, there are no cell culture lines derived from the renal fibroblast population or hepatic Ito cells that produce Epo. The hepatoma cell lines, Hep G2 and Hep 3B, that produce Epo in an oxygen-regulated fashion" are most probably related to the hepatocytic Epo-producing cell population. The current study and previous transgenic experim e n t~~. '~ indicate that the cis-acting sequences controlling Epo expression in hepatocytes may differ from those involved in renal fibroblasts and Ito cells. Nevertheless, physiologic parallels between regulation of the Epo gene in hepatoma cells and in vivo Epo regulation in the kidney indicate that the fundamental mechanism of oxygen-sensing is similar.
There are several phenotypic similarities between the fibroblastoid Epo-producing type 1 interstitial cells of the renal cortex and outer medulla, and the It0 cells of the liver. Both are closely apposed to parenchymal and endothelial cells and possess extensive fine p r o c e s~e s .~~~~~ In both organs they are the major connective tissue producing cells, and they proliferate in response to
Fibroblasts from mouse fetal kidney2* and Ito cells" secrete a cytokine termed hepatocyte growth factor, which appears to influence the growth and differentiation of tubular cellsg0 as well as hepatocytes. As with the renal cell population, Ito cells express ecto-5'-nucleotidase (5'NT). In the renal interstitium, expression of this surface enzyme is specific for type 1 interstitial cells, and expression is increased in response to anemia.3' It is of interest that 5'NT expression in the liver shows zonation in the lobule, with higher expression in the less well oxygenated pericentral region. Schmid et al,I7 using the same antiserum, have recently demonstrated that 5'NT expression on Ito cells is increased in response to anemia. A subset of the renal type 1 interstitial cells expresses the fibroblast-marker ER-TR7,' and we have observed doublelabeling for SV40 T antigen and this marker in the liver of stimulated homozygous Epo-TAg" mice (data not shown). In the kidney, a proportion of type 1 interstitial cells express desmin and in response to injury they become more myofibroblastoid with smooth muscle actin expressionz7 and increased desmin expression (our unpublished observations). Similar phenotypic changes have been reported in Ito cells after liver injury, and after explanation of Ito cells in tissue For personal use only. on June 13, 2017 . by guest www.bloodjournal.org From culture.23 In future work it will be interesting to determine how these changes are related to altered Epo production in hepatic and rend disease.
